Light-Activated ointment targets skin cancer lesions
NCT ID NCT05872854
Summary
This study tested a treatment for early-stage mycosis fungoides, a type of skin lymphoma. Ten participants applied a special ointment to their skin lesions, which was then activated by visible light twice a week for up to a year. The main goal was to see if this treatment could reduce the severity of specific tracked lesions by at least 50%.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, 19034, United States
Conditions
Explore the condition pages connected to this study.